Nikhil Barot, MD
Critical Care Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barot’s office at (650) 723-6381 to ask if they take your plan before you enroll.
California Medical Board record
Licence A99109 · Current
Licensed to practise in California · since 2007 · expires 2026-10-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Hospice and Palliative Medicine
- American Board of Internal Medicine - Pulmonary Disease
Drugs they prescribed that Part D paid
$110,499
Pharmacies billed $110,499 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 37) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
18 generic and 19 brand-name prescriptions · $110,499 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 37 | 13 | 0% (0) | 51% | $110,499 |
| 2023 | 19 | None | 0% (0) | None | $2,209 |
| 2022 | 23 | None | 0% (0) | None | $32,765 |
| 2021 | 51 | None | 0% (0) | 43% | $185,333 |
| 2020 | 31 | None | 0% (0) | 81% | $208,087 |
| 2018 | 44 | 14 | None | 45% | $5,310 |
| 2017 | 38 | 11 | None | 32% | $4,068 |
| 2016 | 34 | None | 0% (0) | 59% | $6,908 |
| 2015 | 57 | None | 0% (0) | 86% | $13,512 |
| 2014 | 21 | None | 0% (0) | 81% | $51,816 |
| 2013 | 32 | None | 0% (0) | 41% | $9,851 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Adempas | 11 | $111,515 | $10,138 |
2015: 2 drugs
| Spiriva | 16 | $7,960 | $498 |
| Dulera | 17 | $4,412 | $260 |
Money from drug and device companies
$613 in 2025
| 2025 | 11 | 23 | None | $613 |
| 2024 | 14 | 27 | None | $702 |
| 2023 | 8 | 10 | None | $304 |
| 2020 | 2 | 2 | None | $34 |
| 2019 | 8 | 21 | None | $418 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insmed | Arikayce | $132 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $111 | 4 payments
|
| United Therapeutics | Tyvaso | $97 | 3 payments
|
| Actelion Pharmaceuticals US | Uptravi | $53 | 2 payments
|
| Medtronic | Illumisite | $49 | 1 payment
|
| Viatris Specialty | Yupelri | $44 | 2 payments
|
See all 22 published payments
| Insmed | Meals · 2025-12-10 | Arikayce | $31 |
| GlaxoSmithKline | Meals · 2025-11-12 | Nucala | $27 |
| Insmed | Meals · 2025-10-29 | Arikayce | $24 |
| Actelion Pharmaceuticals US | Meals · 2025-10-22 | Uptravi | $29 |
| Medtronic | Meals · 2025-09-30 | Illumisite | $49 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-24 | Ofev | $22 |
| Merck Sharp & Dohme | Meals · 2025-09-17 | Winrevair | $27 |
| Philips North America | Meals · 2025-09-10 | Vest Therapy Und | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-03 | Ofev | $28 |
| Insmed | Meals · 2025-08-13 | Arikayce | $25 |
| Baxter Healthcare | Meals · 2025-08-06 | Hillrom - Metaneb System | $31 |
| United Therapeutics | Meals · 2025-07-30 | Tyvaso | $29 |
| Viatris Specialty | Meals · 2025-07-23 | Yupelri | $20 |
| United Therapeutics | Meals · 2025-05-21 | Tyvaso | $34 |
| Verona Pharma | Meals · 2025-05-07 | Ohtuvayre | $22 |
| Viatris Specialty | Meals · 2025-04-08 | Yupelri | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-02 | Ofev | $28 |
| United Therapeutics | Meals · 2025-03-26 | Tyvaso | $33 |
| Insmed | Meals · 2025-03-05 | Arikayce | $26 |
| Actelion Pharmaceuticals US | Meals · 2025-02-19 | Opsumit | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-05 | Ofev | $32 |
| Insmed | Meals · 2025-01-22 | Arikayce | $26 |
See earlier years (2024, 2023, 2020, 2019)
2024: $702
| Amgen | Tezspire | $119 | 5 payments
|
| United Therapeutics | Tyvaso | $92 | 3 payments
|
| Philips North America | (8874) Incourage | $81 | 4 payments
|
| Insmed | Arikayce | $67 | 2 payments
|
| Merck Sharp & Dohme | Winrevair | $58 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $49 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $45 | 2 payments
|
| Atos Medical | Provox Life Home Hme | $36 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $30 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $30 | 1 payment
|
| Medtronic | Puritan Bennett | $29 | 1 payment
|
| Edwards Lifesciences | Hemosphere | $26 | 1 payment
|
| Electromed | Smartvest | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
2023: $304
| Amgen | Tezspire | $48 | 2 payments
|
| Philips Electronics North America | (8874) Incourage | $46 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $44 | 1 payment
|
| Merck Sharp & Dohme | None | $35 | 1 payment
|
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $35 | 1 payment
|
| Astellas Pharma US | Cresemba | $33 | 1 payment
|
| United Therapeutics | Tyvaso | $32 | 1 payment
|
| Olympus America | Evis Exera III Bronchovideoscope | $30 | 1 payment
|
2020: $34
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $15 | 1 payment
|
2019: $418
| Actelion Pharmaceuticals US | Uptravi | $113 | 8 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $83 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $75 | 3 payments
|
| United Therapeutics | Orenitram | $49 | 2 payments
|
| La Jolla Pharmaceutical | Giapreza | $30 | 1 payment
|
| Mallinckrodt Enterprises | Ofirmev | $24 | 1 payment
|
| Genentech USA | Esbriet | $23 | 1 payment
|
| Gilead Sciences | None | $21 | 1 payment
|
Professional record
- NPI
- 1518155928
- Licence
- CA A99109California A99109: Current · expires 2026-10-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 842 Coleman Ave, #20, Menlo Park, CA, 94025
- NPI first listed
- 2007-10-10
- NPI last updated
- 2007-10-10
This is when the NPI record was last certified, not a medical board exam.